Orocobre posts big FY 2020 loss and launches $156 million equity raising

The Orocobre Limited (ASX:ORE) share price is in a trading halt on Friday after launch an equity raising following its FY 2020 results…

| More on:
business man turning out empty pockets

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Orocobre Limited (ASX: ORE) share price won't be going anywhere on Friday after the lithium miner requested a trading halt following its full year results release.

How did Orocobre perform in FY 2020?

It certainly was a tough year for Orocobre following a further collapse in lithium prices amid an oversupply of the battery making ingredient and subdued demand.

For the 12 months ended 30 June 2020, the company posted a 50% decline in revenue to US$77.1 million and a US$67.1 million loss after tax. The latter compares to a net profit after tax of US$65.4 million a year earlier.

This loss includes impairments, foreign exchange movements, and other one-off items.

Potential deal with PPES.

The company also revealed that it has entered into a non-binding memorandum of understanding (MOU) with PPES. This is a joint venture between Toyota and Panasonic which specialises in the production of automotive battery cells.

This MOU is for the long-term supply of product culminating in 30kt of lithium carbonate equivalent in 2025. Management anticipates that the majority of the volume will be in the form of battery grade lithium hydroxide from its existing Naraha plant.

Though, it is worth remembering that MOUs are not legally binding and therefore there is no guarantee that it will go ahead.

Equity raising.

Finally, the reason for the trading halt is Orocobre launching an equity raising this morning.

The lithium miner is aiming to raise $126 million via a fully underwritten placement of 50 million new shares at a price of $2.52 per share. This represents a 13.1% discount to its last close price.

Proceeds from the equity raising will be used to allow the company to fully fund Olaroz Stage 2 and deliver the Olaroz Stage 1 ramp up through a range of operating, COVID-19, and pricing environments, as well as capital for future growth initiatives.

The company will then attempt to raise a further $30 million from retail shareholders via a share purchase plan.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »

Arrows pointing upwards with a man pointing his finger at one.
52-Week Highs

7 ASX All Ords shares smashing new 52-week highs on Tuesday

Do you own any of these stocks at new highs today?

Read more »